Oxprenolol Other names: Oxprenolol hydrochloride

Chemical formula: C₁₅H₂₃NO₃  Molecular mass: 265.348 g/mol  PubChem compound: 4631

Therapeutic indications

Oxprenolol is indicated for:

Cardiac neurosis, hyperkinetic heart syndrome, anxiety induced cardiovascular disorders

Population group: only adults (18 years old or older)

at least one of
Neurocirculatory asthenia
Hyperkinetic heart disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Supraventricular tachycardia, atrial fibrillation, ventricular tachycardia

Population group: only adults (18 years old or older)

at least one of
Supraventricular tachycardia
Atrial fibrillation
Ventricular tachycardia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Angina pectoris

Population group: only adults (18 years old or older)

For long-term prophylactic use (if necessary nitrates should be employed for alleviating acute attacks).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Hypertension

Population group: only adults (18 years old or older)

As monotherapy or for use in combination with other antihypertensives, e.g. with a diuretic, peripheral vasodilator, calcium channel blocker or ACE inhibitor.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Oxprenolol is contraindicated in the following cases:

Cardiogenic shock

Cardiogenic shock

Second or third degree atrioventricular block

at least one of
Second degree atrioventricular block
Complete atrioventricular block

Uncontrolled heart failure

Cardiac failure

Cor pulmonale

Cor pulmonale

Sick-sinus syndrome

Sick sinus syndrome

Bradycardia (<45–50bpm)

Bradycardia

Hypotension

Hypotension

Untreated phaeochromocytoma

Phaeochromocytoma

Severe renal failure

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Prolonged fasting

Fasting

Metabolic acidosis

Metabolic acidosis

Prinzmetal's angina

Prinzmetal angina

Chronic obstructive pulmonary disease

Chronic obstructive lung disease

Bronchial asthma

Airway hyperreactivity

Bronchospasm

Bronchospasm

Severe peripheral arterial circulatory disturbances

Peripheral arterial vascular disease

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2017: TRASICOR Film-coated tablets
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈